I Thinks Doubt Thes Continued Interest Frompharmacuticals, Mmonty, Nationals in the Area.

15 companies ind clinical trials now with traditional protax targeting, you know, ose the the original targets. There's a start up based around her technology, the light actim technology, using anti bodies. But there's also other people who are kind of looking into small molecules. So this is really exciting space. And a really excited to hear what ray and caroline have to say about it.